Lytix Biopharma AS (LYTIX) — Cash Flow Reinvestment Rate
Latest as of September 2021:
0.00x
Lytix Biopharma AS (LYTIX) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting Nkr35.00K (capex Nkr35.00K ) from operating cash flow of Nkr138.23 Million. Explore how efficiently does Lytix Biopharma AS generate cash to assess how effectively this company generates cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Nkr35.00K
Capex + Investments
Operating Cash Flow
Nkr138.23 Million
NOK
Capital Expenditures
Nkr35.00K
NOK
Annual Cash Flow Reinvestment Rate for Lytix Biopharma AS (None–None)
Year-by-year capital reinvestment analysis for Lytix Biopharma AS. For live market cap and broader valuation context, see Lytix Biopharma AS stock valuation.
| Year | Reinvestment Rate | Total Reinvested (NOK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow